BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33613498)

  • 1. Outer Membrane Vesicle Induction and Isolation for Vaccine Development.
    Balhuizen MD; Veldhuizen EJA; Haagsman HP
    Front Microbiol; 2021; 12():629090. PubMed ID: 33613498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
    Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
    Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer Membrane Vesicles of Bordetella pertussis Encapsulated into Sodium Alginate Nanoparticles as Novel Vaccine Delivery System.
    Rami A; Kazemi-Lomedasht F; Mirjalili A; Noofeli M; Shahcheraghi F; Dounighi NM
    Curr Pharm Des; 2021; 27(42):4341-4354. PubMed ID: 34493192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Two Different Methods for the Extraction of Outer Membrane Vesicles from the
    Soltani MS; Eftekhar F; Noofeli M; Banihashemi SR; Shahcheraghi F
    Arch Razi Inst; 2021; 76(3):411-419. PubMed ID: 34824734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yılmaz Çolak Ç; Tefon Öztürk BE
    Pathog Glob Health; 2023 Jun; 117(4):342-355. PubMed ID: 36047634
    [No Abstract]   [Full Text] [Related]  

  • 9. PMAP-36 reduces the innate immune response induced by
    Balhuizen MD; Versluis CM; van Harten RM; de Jonge EF; Brouwers JF; van de Lest CHA; Veldhuizen EJA; Tommassen J; Haagsman HP
    Curr Res Microb Sci; 2021 Dec; 2():100010. PubMed ID: 34841304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock enhances outer-membrane vesicle release in
    de Jonge EF; Balhuizen MD; van Boxtel R; Wu J; Haagsman HP; Tommassen J
    Curr Res Microb Sci; 2021 Dec; 2():100009. PubMed ID: 34841303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for the extraction of outer membrane vesicles (OMVs) from
    Sekhavati M; Mobarez AM; Siadat SD; Noofeli M
    Iran J Microbiol; 2020 Feb; 12(1):37-42. PubMed ID: 32322378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Outer Membrane Vesicle Isolation Methods With an
    Reimer SL; Beniac DR; Hiebert SL; Booth TF; Chong PM; Westmacott GR; Zhanel GG; Bay DC
    Front Microbiol; 2021; 12():628801. PubMed ID: 33746922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer Membrane Vesicle Vaccine Platforms.
    Micoli F; Adamo R; Nakakana U
    BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
    Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
    mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis.
    Gerritzen MJH; Martens DE; Uittenbogaard JP; Wijffels RH; Stork M
    Sci Rep; 2019 Mar; 9(1):4716. PubMed ID: 30886228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Growth Stage and Isolation Method on Properties of ClearColi™ Outer Membrane Vesicles (OMVs).
    Sharif E; Eftekhari Z; Mohit E
    Curr Microbiol; 2021 Apr; 78(4):1602-1614. PubMed ID: 33687512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
    Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
    Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane vesicles as platform vaccine technology.
    van der Pol L; Stork M; van der Ley P
    Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.